Surgical Considerations for the Human Implantation of the Gore Synthetic Corneal Device.
Arturo Ramirez-Miranda, Gustavo Ortiz-Morales, Jorge L Domene-Hickman...
https://pubmed.ncbi.nlm.nih.gov/40810416Actively Recruiting
Led by W.L.Gore & Associates · Updated on 2025-12-04
10
Participants Needed
2
Research Sites
208 weeks
Total Duration
Researchers are evaluating the initial safety and effectiveness of the GORE Synthetic Cornea Device in treating loss of corneal clarity in patients who need corneal transplantation. This early feasibility study is prospective, open-label, single-arm, and conducted across multiple centers. It aims to assess clinical outcomes in patients with corneal opacity who are candidates for this procedure. Participants will receive treatment with the GORE Synthetic Cornea Device. After the procedure, they will have scheduled clinical follow-up visits over a 12-month study period to monitor their progress and device performance. The study may extend follow-up examinations up to 60 months if patients agree to continue. During the study, participants will undergo evaluations including visual acuity tests and assessments for adverse events related to the device and surgery. Researchers will track device retention, surgical complications, and any need for secondary interventions. Safety and effectiveness outcomes will be monitored through regular clinical exams, with the primary measures focused on safety events at the initial procedure and during the 12 months after treatment.
CONDITIONS
Clinical Outcomes of the Gore Synthetic Cornea Device
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Day of procedure
Participants undergo implantation of the GORE Synthetic Cornea Device as treatment for loss of corneal clarity.
1 procedure visit (in-person)
Duration - Up to 1 week post-procedure
Participants receive clinical follow-up immediately after the device implantation to monitor safety and early outcomes.
Several visits within the first week after surgery (in-person)
Duration - Up to 12 months
Participants attend scheduled clinical follow-up visits to assess device retention, visual acuity improvement, and monitor for adverse events.
Regular visits over 12 months (in-person)
Total: 2 locations
1
Asociación para Evitar la Ceguera en México, I.A.P
Mexico City, Mexico
Not Yet Recruiting
2
Instituto de Oftalmología Fundación de Asistencia Privada Conde Valenciana I.A. P.
Mexico City, Mexico
Actively Recruiting
A
Anuraag Singh
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DEVICE_FEASIBILITY
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Arturo Ramirez-Miranda, Gustavo Ortiz-Morales, Jorge L Domene-Hickman...
https://pubmed.ncbi.nlm.nih.gov/40810416